O2h Ventures — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Five Alarm Bio develops pharmaceutical compounds targeting a novel aging mechanism to prevent and treat age-related chronic diseases.
BiotechLongevity
William Bains(Founding scientist)in
Co-investorsCambridge Angels groupSyndicateRoom
Pencil is an AI operating system for enterprise marketing teams that turns a campaign brief into finished images, video, and copy, automating generation, in-browser editing, multi-stakeholder review, publishing, and performance prediction.
AI & Machine LearningEnterprise SoftwareMarketing TechSingapore, SG
Will Hanschell(CEO)inSumukh Avadhani(CTO)in
Co-investorsBrandtech VenturesEntrepreneur FirstWavemaker PartnersArtesianCatapult VenturesMartlet Capital+6 more
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.
AI & Machine LearningBiotechDeep Tech
Hannah Sore(Founder)in
Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesDiamond Edge VenturesParkwalk AdvisorsWren Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












